The Middle EAST Nexletol Market was valued at USD 0.15 billion in 2024 and is projected to reach USD 0.45 billion by 2034, registering a CAGR of 12.00%. This growth trajectory is underpinned by several factors, including an increasing prevalence of cardiovascular diseases, rising awareness of cholesterol management, and the growing adoption of advanced therapeutic solutions. According to the...